Philippines Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Philippines Pharmaceuticals and Healthcare Report

Philippines Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Philippines Pharmaceuticals and Healthcare Report
Published Oct 01, 2016
100 pages — Published Oct 01, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

One of the highest regional rates of private health spending as a percentage of total health expenditure. Only a third of the population has adequate access to pharmaceuticals, with manufacturers also accused of sabotaging authorities efforts to lower prices. ...One of the highest regional rates of private health spending as a percentage of total health expenditure. Only a third of the population has adequate access to pharmaceuticals, with manufacturers also accused of sabotaging authorities efforts to lower prices. Counterfeiting, lack of enforcement and poor patent and data protection are the main regulatory problems. ...Most healthcare provision is concentrated in Metro Manila. Government pharmacies are unevenly distributed across the country and suffer from operational issues, such as limited number of available medicines and inadequate professional support.

...The ASEAN harmonisation initiative and the adoption of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use and WHO guidelines. Need for cost containment and new legislation, which does not allow for patents for newly discovered uses of a known drug, to boost generic drug consumption. ...The ASEAN harmonisation initiative and the adoption of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use and WHO guidelines. Need for cost containment and new legislation, which does not allow for patents for newly discovered uses of a known drug, to boost generic drug consumption. Potential for a more stringent (and better funded) regulatory body following the establishment of the Philippine Food & Drug Administration. ...The government s commitment to the implementation of the recently approved universal healthcare insurance coverage by ----. The introduction of fiscal and regulatory incentives for orphan drug manufacturers, with the Rare Disease Act of the Philippines setting the foundation.

...In August ----, campaigners called on Filipino authorities to increase their efforts in tackling HIV infections after the country posted a record --- new cases of the potentiality deadly disease in June. In August ----, the Philippines Department of Health (DOH) reported an additional --,--- cases of dengue fever from the previous month, bringing the total to around --,--- reported cases since the beginning of the year. ...

  
Source:
Document ID
1748-376X
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Philippines Pharmaceuticals and Healthcare Report" Oct 01, 2016. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Philippines-Pharmaceuticals-and-Healthcare-Report-2026-119>
  
APA:
Business Monitor International - Industry Reports. (2016). Philippines Pharmaceuticals and Healthcare Report Oct 01, 2016. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Philippines-Pharmaceuticals-and-Healthcare-Report-2026-119>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.